CODEXIS INC Contracts & Agreements

Description of Codexis' Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2024)

Acquisition Agre (Filed With SEC on February 28, 2024)

Loan and Security Agreement (Filed With SEC on February 28, 2024)

Form of Warrant to Purchase Common Stock for Codexis, Inc (Filed With SEC on February 13, 2024)

Assignment and Assumption of Lease by and between the Company and Vaxcyte, Inc. dated as of September 1, 2023 (Filed With SEC on November 3, 2023)

Consent to Assignment and First Amendment to Lease Agreement by and between the Company, Vaxcyte Inc. and ARE-San Francisco No. 63, LLC dated as of September 6, 2023 (Filed With SEC on November 3, 2023)

Codexis, Inc. 2023 Employee Stock Purchase Plan (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K, filed on June 16, 2023) (Filed With SEC on August 3, 2023)

Amendment to the Codexis, Inc. 2019 Incentive Award Plan (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K, filed on June 16, 2023) (Filed With SEC on August 3, 2023)

Codexis, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on June 16, 2023)

Amendment to the Codexis, Inc. 2019 Incentive Award Plan (Filed With SEC on June 16, 2023)

Termination of the Loan and Security Agreement by and between the Company and Western Alliance Bank dated as of March 13, 2023 (Filed With SEC on May 4, 2023)

Amendment No. 3 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (Filed With SEC on May 4, 2023)

Form of Indemnification Agreement between the Company and each of its directors, officers and certain employees (Filed With SEC on February 27, 2023)

Transition and Separation Agreement by and between the Company and Ross Taylor, dated as of February 3, 2023 (Filed With SEC on February 27, 2023)

Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, dated as of July 14, 2022 (Filed With SEC on February 27, 2023)

Amendment No. 1 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of December 19, 2022 (Filed With SEC on February 27, 2023)

Amendment No. 2 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of February 1, 2023 (Filed With SEC on February 27, 2023)

Offer Letter by and between the Company and Margaret Fitzgerald dated as of October 5, 2022 (Filed With SEC on February 27, 2023)

Change in Control Severance Agreement by and between the Company and Margaret Fitzgerald dated October 10, 2022 (Filed With SEC on February 27, 2023)

Offer Letter by and between the Company and Sriram Ryali dated as of December 30, 2023 (Filed With SEC on February 27, 2023)

Change in Control Severance Agreement by and between the Company and Sriram Ryali dated January 27, 2023 (Filed With SEC on February 27, 2023)

Transition and Separation Agreement by and between (Filed With SEC on November 4, 2022)

Employment Agreement by and between the Company and Stephen Dilly (Filed With SEC on November 4, 2022)

Offer Letter by and between the Company and Kevin Norrett (Filed With SEC on November 4, 2022)

Change in Control Severance Agreement by and between the Company and Kevin Norrett dated September 12, 2022 (Filed With SEC on November 4, 2022)

Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (Filed With SEC on November 4, 2022)

Description of Codexis' Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2022)

Amendment No. 5 to Sitagliptin Supply Agreement, effective as of July 1, 2021, by and between Codexis, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on November 5, 2021)

Ninth Amendment to Loan and Security Agreement, effective as of September 30, 2021, by and between Codexis, Inc. and Western Alliance Bank (Filed With SEC on November 5, 2021)

Equity Distribution Agreement, dated as of May 7, 2021, between Codexis, Inc. and Piper Sandler & Co (Filed With SEC on May 7, 2021)

Lease Agreement by and between the Company and ARE-San Francisco No. 63, LLC. dated as of (Filed With SEC on May 7, 2021)

Underwriting Agreement, dated as of December 2, 2020, among Codexis, Inc. and Jefferies LLC, Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated, as... (Filed With SEC on December 7, 2020)

Eighth Amendment to Loan and Security Agreement by and between the Company and Western Alliance Bank dated as of September 30, 2020 to Loan and Security (Filed With SEC on November 6, 2020)

Strategic Collaboration and License Agreement, effective as of March 23,202, by and between Codexis, Inc. and Shire Human Genetic Therapies, Inc., a wholly-owned subsidiary of... (Filed With SEC on May 8, 2020)

Letter Agreement, effective as of February 21, 2020, by and between Codexis, Inc. and GlaxoSmithKline Intellectual Property Development Limited (Filed With SEC on May 8, 2020)

Description of the Common Stock of Codexis, In (Filed With SEC on February 28, 2020)

Form of Amended and Restated Change in Control Severance Agreement between the Company and certain of its officers (Filed With SEC on November 6, 2019)

Employment Agreement by and between the Company and Ross Taylor effective as of August 4, 2019 (Filed With SEC on November 6, 2019)

Amendment to Employment Agreement between the Company and John Nicols, effective as of June 28, 2019 (Filed With SEC on November 6, 2019)

Sixth Amendment to Loan and Security Agreement by and between the Company and Western Alliance Bank dated as of July 11, 2019 (Filed With SEC on November 6, 2019)

Seventh Amendment to Loan and Security Agreement by and between the Company and Western Alliance Bank dated as of September 30, 2019 (Filed With SEC on November 6, 2019)

Platform Technology Transfer and License Agreement, dated May 2, 2019, by and between the Company and Novartis Pharma AG (Filed With SEC on August 6, 2019)

Securities Purchase Agreement, dated as of June 20, 2019, by and between Codexis, Inc. and Casdin Partners Master Fund, L.P (Filed With SEC on June 20, 2019)

Registration Rights Agreement, dated as of June 20, 2019, by and between Codexis, Inc. and Casdin Partners Master Fund, L.P (Filed With SEC on June 20, 2019)

Codexis, Inc. 2019 Incentive Award Plan (Filed With SEC on June 12, 2019)

Amendment No. 2 to Platform Technology Transfer and License Agreement by and between Merck and the Company dated as of January 1, 2019 (Filed With SEC on May 8, 2019)

Fifth Amendment to Loan and Security Agreement effective as of January 23, 2019 by and between the Company and Western Alliance Bank (Filed With SEC on May 8, 2019)

Eighth Amendment to Lease, effective as of February 8, 2019, by and between the Company and Metropolitan Life Insurance Company (Filed With SEC on May 8, 2019)

Amendment No. 1 to Global Development, Option and License Agreement by and among the Company, Nestec Ltd. and Nestl Health Science S.A., effective as of July 26, 2018 (Filed With SEC on March 1, 2019)

Letter Agreement to Global Development, Option and License Agreement by and among the Company, Nestec Ltd. and Nestle Health Science S.A., effective as of December 12, 2018 (Filed With SEC on March 1, 2019)

Amendment No. 1 to Platform Technology Transfer and License Agreement by and between the Company and Merck Sharp & Dohme Corp., dated as of October 10, 2018 (Filed With SEC on March 1, 2019)

Separation Agreement by and between Michael Aldridge and the Company, dated August 17, 2018 (Filed With SEC on March 1, 2019)

Third Amendment to Loan and Security Agreement by and between the Company and Western Alliance Bank dated as of June 29, 2018 (Filed With SEC on August 9, 2018)

Underwriting Agreement, dated as of April 5, 2018, among Codexis, Inc. and Jefferies LLC and Cowen and Company, LLC, as representatives of the underwriters named therein (Filed With SEC on April 10, 2018)

Form of Amendment to Change of Control Severance Agreement by and between Codexis, Inc. and certain of its officers (Filed With SEC on March 15, 2018)

Amendment to Employment Agreement between the Company and John Nicols, dated November 16, 2017 (Filed With SEC on March 15, 2018)

Global Development, Option and License Agreement by and among the Company, Nestec Ltd. and Nestl Health Science S.A., effective as of October 12, 2017 (Filed With SEC on March 15, 2018)

First Amendment to Loan and Security Agreement effective as of September 28, 2017 by and between the Company and Western Alliance Bank (incorporated by reference to Exhibit 10.1... (Filed With SEC on March 15, 2018)

Second Amendment to Loan and Security Agreement effective as of November 7, 2017 by and between the Company and Western Alliance Bank (Filed With SEC on March 15, 2018)

First Amendment to Loan and Security Agreement effective as of September 28, 2017 by and between Codexis, Inc., a Delaware corporation (Borrower), having a place of business at... (Filed With SEC on November 9, 2017)

CODEXIS, INC., A DELAWARE CORPORATION WESTERN ALLIANCE BANK, AN ARIZONA CORPORATION LOAN AND SECURITY AGREEMENT (Filed With SEC on August 9, 2017)

5,500,000 Shares Codexis, Inc. UNDERWRITING AGREEMENT (Filed With SEC on April 10, 2017)

AMENDMENT NO. 4 TO SITAGLIPTIN SUPPLY AGREEMENT (Filed With SEC on November 8, 2016)

SEVENTH AMENDMENT TO LEASE (Filed With SEC on November 8, 2016)

CODEXIS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on October 14, 2016)

Codexis, Inc. 200 Penobscot Drive Redwood City, CA 94063 Tel: 650 ###-###-#### www.codexis.com (Filed With SEC on May 9, 2016)

AMENDMENT NO. 3 TO SITAGLIPTIN SUPPLY AGREEMENT (Filed With SEC on March 8, 2016)

AMENDMENT NO. 2 TO SITAGLIPTIN SUPPLY AGREEMENT (Filed With SEC on May 7, 2015)

CODEXIS, INC. CONSULTING AGREEMENT (Filed With SEC on March 13, 2014)

TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on March 13, 2014)

TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on November 12, 2013)

AMENDMENT TO SUPPLY AGREEMENT (Filed With SEC on November 12, 2013)

TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on August 9, 2013)

ENZYME SUPPLY AGREEMENT (Filed With SEC on April 2, 2013)

SITAGLIPTIN CATALYST SUPPLY AGREEMENT By and Between MERCK SHARP AND DOHME CORP And CODEXIS, INC. SITAGLIPTIN CATALYST SUPPLY AGREEMENT (Filed With SEC on April 2, 2013)

LICENSE AGREEMENT (Filed With SEC on April 2, 2013)

AMENDMENT NO. 1 TO THE LICENSE AGREEMENT (Filed With SEC on April 2, 2013)

EXCLUSIVE NEGOTIATION AGREEMENT (Filed With SEC on November 7, 2012)

AGREEMENT (Filed With SEC on November 7, 2012)

CODEXIS, INC. DAVID OTOOLE STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (Filed With SEC on November 7, 2012)

CODEXIS, INC. DAVID OTOOLE RESTRICTED STOCK GRANT NOTICE AND RESTRICTED STOCK AGREEMENT (Filed With SEC on November 7, 2012)

SIXTH AMENDMENT TO LEASE (Filed With SEC on November 7, 2012)

Codexis, Inc. and Wells FargoBank, N.A. as Rights Agent Rights Agreement Dated as of September 3, 2012 RIGHTS AGREEMENT (Filed With SEC on September 4, 2012)

Employment Agreement (Filed With SEC on August 9, 2012)

CODEXIS, INC. JOHN NICOLS STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT (Filed With SEC on August 9, 2012)

CODEXIS, INC. JOHN NICOLS RESTRICTED STOCK GRANT NOTICE AND RESTRICTED STOCK AGREEMENT (Filed With SEC on August 9, 2012)

AMENDMENT NO. 1 TO MANUFACTURE AND SUPPLY AGREEMENT (Filed With SEC on May 10, 2012)

Codexis, Inc. 200 Penobscot Drive Redwood City, CA 94063 Tel: 650 ###-###-#### www.codexis.com (Filed With SEC on May 10, 2012)

AMENDMENT NO. 1 TO ENZYME AND PRODUCT SUPPLY AGREEMENT (Filed With SEC on March 5, 2012)

TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on March 5, 2012)

AMENDMENT NO. 1 TO MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING AND ROYALTY CALCULATION (Filed With SEC on November 7, 2011)

AMENDMENT NO. 1 TO MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING (Filed With SEC on November 7, 2011)

MANUFACTURE AND SUPPLY AGREEMENT (Filed With SEC on August 3, 2011)

FIFTH AMENDMENT TO LEASE (Filed With SEC on May 6, 2011)

FOURTH AMENDMENT TO LEASE (Filed With SEC on November 4, 2010)

ASSET PURCHASE AGREEMENT between: CODEXIS, INC. a Delaware corporation, CODEXIS MAYFLOWER HOLDINGS, LLC a Delaware limited liability company, and MAXYGEN, INC. a Delaware... (Filed With SEC on October 28, 2010)

ENZYME AND PRODUCT SUPPLY AGREEMENT (Filed With SEC on April 16, 2010)

LOAN AND SECURITY AGREEMENT (Filed With SEC on April 5, 2010)

LICENSE AGREEMENT (Filed With SEC on April 5, 2010)

AMENDED AND RESTATED COLLABORATIVE RESEARCH AGREEMENT (Filed With SEC on April 5, 2010)

AMENDMENT TO THE AMENDED AND RESTATED COLLABORATIVE (Filed With SEC on April 5, 2010)

AMENDMENT NO. 2 TO THE AMENDED AND RESTATED COLLABORATIVE RESEARCH AGREEMENT (Filed With SEC on April 5, 2010)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on April 5, 2010)

AMENDMENT TO THE AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on April 5, 2010)

COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (Filed With SEC on April 5, 2010)

LICENSE AGREEMENT (Filed With SEC on April 5, 2010)

ENZYME AND PRODUCT SUPPLY AGREEMENT (Filed With SEC on April 5, 2010)

MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING AND ROYALTY CALCULATION (CODEXIS INC.) (Filed With SEC on April 5, 2010)

MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING (CODEXIS INDIA) (Filed With SEC on April 5, 2010)

Shares CODEXIS,INC. Common Stock, par value $0.0001 per share FORM OF UNDERWRITING AGREEMENT (Filed With SEC on March 31, 2010)

CODEXIS, INC. 2010 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on March 31, 2010)

CODEXIS, INC. FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on March 31, 2010)

CODEXIS, INC. FIFTH AMENDED AND RESTATED VOTINGAGREEMENT (Filed With SEC on March 26, 2010)

CODEXIS, INC. AMENDMENT (Filed With SEC on March 26, 2010)

AMENDMENT NO. 2 TO THE AMENDED AND RESTATED COLLABORATIVE RESEARCH AGREEMENT (Filed With SEC on February 26, 2010)

PRODUCT SUPPLY AGREEMENT (Filed With SEC on February 26, 2010)

ENZYME AND PRODUCT SUPPLY AGREEMENT (Filed With SEC on February 26, 2010)

MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING AND ROYALTY CALCULATION (CODEXISINC.) (Filed With SEC on February 26, 2010)

MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING (CODEXIS INDIA) (Filed With SEC on February 26, 2010)

CODEXIS, INC. CONSULTING AGREEMENT (Filed With SEC on February 26, 2010)

Category (Filed With SEC on February 26, 2010)

COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (Filed With SEC on February 17, 2010)

AMENDMENT TO SEPARATION AGREEMENT (Filed With SEC on February 1, 2010)

2008 CODEXIS EXECUTIVE INCENTIVE COMPENSATION PLAN (Filed With SEC on February 1, 2010)

2009 CODEXIS EXECUTIVE INCENTIVE COMPENSATION PLAN (Filed With SEC on February 1, 2010)

CODEXIS, INC. CHANGE OF CONTROL SEVERANCEAGREEMENT (Filed With SEC on February 1, 2010)

AMENDED AND RESTATED COLLABORATIVE RESEARCH AGREEMENT (Filed With SEC on January 14, 2010)

AMENDMENT TO THE AMENDED AND RESTATED COLLABORATIVE (Filed With SEC on January 14, 2010)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on January 14, 2010)

AMENDMENT TO THE AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on January 14, 2010)

LICENSE AGREEMENT (Filed With SEC on January 14, 2010)

CODEXIS, INC. FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT March 4, 2009 TABLE OF CONTENTS (Filed With SEC on December 28, 2009)

CODEXIS, INC. (Filed With SEC on December 28, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 28, 2009)

CODEXIS, INC. STOCK PURCHASE WARRANT (Filed With SEC on December 28, 2009)

WARRANT TO PURCHASE SHARES OFSERIES D CONVERTIBLE PREFERRED STOCK (Filed With SEC on December 28, 2009)

Void after February 9, 2016 WARRANT FOR THE PURCHASE OF SHARES OF COMMON STOCK (Filed With SEC on December 28, 2009)

A. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 28, 2009)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 28, 2009)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 28, 2009)

LICENSE AGREEMENT (Filed With SEC on December 28, 2009)

AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on December 28, 2009)

AMENDMENT NO. 2 TO LICENSE AGREEMENT (Filed With SEC on December 28, 2009)

AMENDMENT NO. 3 TO LICENSE AGREEMENT (Filed With SEC on December 28, 2009)

LEASE BETWEEN (Filed With SEC on December 28, 2009)

FIRST AMENDMENT TO LEASE (Filed With SEC on December 28, 2009)

SECOND AMENDMENT TO LEASE (Filed With SEC on December 28, 2009)

THIRD AMENDMENT TO LEASE (Filed With SEC on December 28, 2009)

MASTER SECURITYAGREEMENT No. 5081102 Dated as of October 25, 2005 (Agreement) (Filed With SEC on December 28, 2009)

CODEXIS, INC. 2002 STOCK PLAN (Filed With SEC on December 28, 2009)

CODEXIS, INC. CHANGEOF CONTROL AGREEMENT (Filed With SEC on December 28, 2009)

SEPARATION AGREEMENT (Filed With SEC on December 28, 2009)

CODEXIS, INC. CHANGEOF CONTROL AGREEMENT (Filed With SEC on December 28, 2009)

CONTRACT OF EMPLOYMENT (Filed With SEC on December 28, 2009)

INDEMNIFICATION AGREEMENT (Filed With SEC on December 28, 2009)

W I T N E S S E T H: (Filed With SEC on August 4, 2008)

BACKGROUND (Filed With SEC on August 4, 2008)

AGREEMENT (Filed With SEC on August 4, 2008)

CODEXIS, INC. FOURTH AMENDED AND RESTATED (Filed With SEC on April 14, 2008)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on April 14, 2008)

CODEXIS, INC. STOCK PURCHASE WARRANT (Filed With SEC on April 14, 2008)

WARRANT TO PURCHASE SHARES OF SERIES D CONVERTIBLE PREFERRED STOCK (Filed With SEC on April 14, 2008)

A. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 14, 2008)

LOAN AND SECURITYAGREEMENT (Filed With SEC on April 14, 2008)

W I T N E S S E T H: (Filed With SEC on April 14, 2008)

BACKGROUND (Filed With SEC on April 14, 2008)

[THE REMAINDER OF THIS PAGE HAS BEEN INTENTIONALLY LEFT BLANK] (Filed With SEC on April 14, 2008)

AMENDMENT NO. 2 TO LICENSE AGREEMENT (Filed With SEC on April 14, 2008)

[THE REMAINDER OF THIS PAGE HAS BEEN INTENTIONALLY LEFT BLANK] (Filed With SEC on April 14, 2008)

AMENDED AND RESTATED COLLABORATIVE RESEARCH AGREEMENT (Filed With SEC on April 14, 2008)

LEASE BETWEEN METROPOLITAN LIFE INSURANCE COMPANY (LANDLORD) AND CODEXIS, INC. (TENANT) SEAPORT CENTRE (Filed With SEC on April 14, 2008)

FIRST AMENDMENT TO LEASE (Filed With SEC on April 14, 2008)

SECOND AMENDMENT TO LEASE (Filed With SEC on April 14, 2008)

THIRD AMENDMENT TO LEASE (Filed With SEC on April 14, 2008)

LOAN AND SECURITY AGREEMENT (Filed With SEC on April 14, 2008)

MASTER SECURITY AGREEMENT (Filed With SEC on April 14, 2008)

CODEXIS, INC. 2002 STOCK PLAN (as amended through August 28, 2007) (Filed With SEC on April 14, 2008)

Category

Industry

Companies

Contracts

CODEXIS INC Contracts & Agreements